Management, body systems, and case studies in COVID-19 / edited by Rajkumar Rajendram [and three others].

Format:

Book

Contributor:

Rajendram, Rajkumar, editor.

Language:

English

Subjects (All):

COVID-19 (Disease)--Complications.

COVID-19 (Disease).

Physical Description:

1 online resource (624 pages)

Edition:

First edition.

Place of Publication:

London, England : Academic Press, [2024]

Summary:

This comprehensive volume, edited by Rajkumar Rajendram and colleagues, explores the multifaceted impact of COVID-19 on medical management and body systems. It includes in-depth analyses of hand hygiene strategies, vaccine development, molecular detection methods for SARS-CoV-2, and the management of various medical conditions during the pandemic such as respiratory diseases, inflammatory bowel diseases, and rheumatic diseases. The book also addresses the nutritional needs of COVID-19 patients, ethical allocation of personal protective equipment, and the use of ultrasound in diagnosing and managing COVID-19 complications. Targeted towards medical professionals and researchers, it aims to provide up-to-date knowledge and best practices for managing COVID-19 effectively. Generated by AI.

Contents:

Intro

Management, Body Systems, and Case Studies in COVID-19

Copyright

Dedication

Contents

Contributors

Preface

Section A: Introductory chapters and setting the scene

Chapter 1: Hand hygiene strategies

Introduction

Soaps

Types of soaps

Classification by chemical synthesis: Soaps and syndets

Classification by type of surfactant

Classification by commercial presentation

Effectiveness of soap in hand hygiene

Adverse skin manifestations related to soaps

Hand sanitizers

Types of hand sanitizers

Effectiveness of hand sanitizers in hand hygiene

Adverse skin manifestations related to hand sanitizers

Comparison between soaps and hand sanitizers

Impact of COVID-19 on hand hygiene

Changes in hand hygiene products during COVID-19

Social awareness

Skin manifestations

Policies and procedures

Applications to other areas

Mini-dictionary of terms

Summary points

References

Chapter 2: Approved vaccines for the COVID-19 pandemic: Linking in future perspectives

Rapid COVID-19 vaccine development

Current and most common COVID-19 Vaccines

Vaccination strategies to fight against variants of concern

The versatility of mRNA platform for vaccine development and the emergence of variants of concerns (VoCs)

Strategies for new vaccine development

Alternative routes of vaccine administration

Intranasal vaccine

Other mucosal routes of vaccination

Policies

Chapter 3: Molecular methods for SARS-CoV-2 variant detection

Sequencing methods for detection of SARS-CoV-2 variants

Next-generation sequencing (NGS) technology

NGS target enrichment

Shotgun metagenomic sequencing

Sanger sequencing.

PCR-based methods for detection of SARS-CoV-2 variants

Reverse transcription quantitative PCR (RT-qPCR)

Reverse transcription fluorescence resonance energy transfer polymerase chain reaction (RT-FRET-PCR)

Allele-specific polymerase chain reaction (ASP)

High-resolution melting (HRM) assay

LAMP assay

Reverse transcription-recombinase polymerase amplification (RT-RPA)

RT-ddPCR (reverse transcriptase droplet digital PCR)

CRISPR-Cas-based detection

Protein-based variant SARS-CoV-2 detection

Antigen-based detection

Antibody-based detection

Mass spectrometry

Conclusions and perspectives

Section B: Management

Chapter 4: Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes ...

Collaborative approach to quality improvement, training, and patient safety

The challenge of following guidelines during an evolving pandemic

Focusing on cognitive aids to reduce errors in patient assessment and diagnosis

Development of the SPARTA proforma

Important features of the SPARTA proforma

Procedures: How to use the SPARTA proforma in clinical practice

Conclusion

Chapter 5: Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19

Pulmonary pathology in COVID-19

Diagnosis of SARS-CoV-2 infection and pneumonia

Triage

PoCUS protocols and scoring systems for pulmonary pathology in COVID-19

PoCUS for the cardiovascular complications of COVID-19

PoCUS for the guidance of fluid management in patients with COVID-19

PoCUS for the thromboembolic complications of COVID-19.

Multiorgan PoCUS protocols

The use of handheld ultrasound devices during the COVID-19 pandemic

Conclusions

Chapter 6: COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines

SARS-CoV-2 and the gastrointestinal tract

COVID-19 gastrointestinal symptoms

Risk of COVID-19 in inflammatory bowel disease

Outcomes of COVID-19 in IBD

COVID-19 gastrointestinal symptoms in IBD

Risk of severe COVID-19 and mortality in IBD

Risk factors for severe COVID-19

Persistent COVID-19 in IBD

Impact of COVID-19 on IBD disease activity and incident IBD

Impact of pandemic waves

Vulnerable IBD populations

Effect of IBD medications on COVID-19 outcomes

Biologics and small molecules

Immunomodulators and combinations

5-Aminosalicylates

Corticosteroids

Management of IBD during the COVID-19 pandemic

Treatments for IBD during pandemic

Endoscopy during the COVID-19 pandemic and postpandemic period

SARS-CoV-2 vaccines in patients with IBD

Immunological response to vaccines

Impact of treatments on response to vaccines

Efficacy of SARS-CoV-2 vaccines in IBD

Safety

Policies and procedures in IBD

Chapter 7: Management of COVID-19 and clinical nutrition

Nutrition of the COVID-19 nondysphagic patient

Artificial nutrition of the COVID-19 patient

Microbiota and COVID-19

General aspects

Which subjects are at risk of dysbiosis

Use of probiotics and prebiotics in the nutrition of the COVID-19 patient

Use of probiotics in the critical patient

The possible risks of probiotics in nutrition

Conclusions.

Role of vitamins and minerals in the prevention and treatment of SARS-CoV-2 infection

Vitamin D

Vitamin D deficiency in the population

Proposed mechanisms

Evidence supporting the importance of vitamin D in nutrition

Vitamin C, zinc in COVID-19 patient

Chapter 8: The management of head and neck cancer in COVID-19

Consultation care

Diagnostic tests

Surgical prioritization criteria

Treatment options

Minidictionary of terms

Chapter 9: The COVID-19 pandemic: Inventory management and allocation of personal protective equipment

An unprecedented global challenge

Ethical principles for scarce resource distribution in pandemics

Emmanuel et al.

Dawson et al.

Moodley et al.

Srinivas et al.

Summary

Ethical allocation of personal protective equipment

Principles in considering PPE management strategies

Binkley and Kemp

Sureka et al.

Modeling fair allocation of PPE

Domnez et al.

Wang et al.

Public Health Guidelines on PPE allocation

Grassroot initiative strategies

Recommendations for distribution and inventory management

Chapter 10: Clinical management in the COVID-19 pandemic: Rheumatic disease

Methods, policies, and procedures

General recommendation for RD patients to prevent COVID-19

Telerheumatology-based clinical management

Survey based clinical management

Evidence and guideline-based management of RD

Prevalence, severe disease, and mortality of COVID-19 in patients with RD.

The impact of antirheumatic drugs on SARS-CoV-2

Glucocorticoids

Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs)

Biological disease-modifying antirheumatic drugs (bDMARDs) and JAKinibs

Immunosuppressants

The management of antirheumatic drugs after COVID-19 vaccination

Chapter 11: Managing migraines during the COVID-19 pandemic: An Italian experience

Procedures

How to handle patients on the waiting list for clinical evaluation

How to manage patients who were waiting to start our behavioral program that was generally conducted in small face-to-face ...

Details of the program

How to handle patients who were waiting for a withdrawal program for CM-MOH: The BeHome program

How to handle the management of pediatric and adolescent patients: The BeHome kids program

Chapter 12: Managing acute ischemic stroke in the SARS-CoV-2 pandemic

COVID-19 infection and acute ischemic stroke

Pathophysiology of AIS in COVID-19

Reviewing the evidence: What is the relationship between COVID-19 and AIS?

Characteristics of AIS in patients with and without COVID-19 infection

Characteristics of COVID-19 patients with and without AIS

COVID-19 vaccination and AIS

Impact of the COVID-19 pandemic on AIS presentation and management

Impact of the COVID-19 pandemic on endovascular thrombectomy of AIS

AIS presentation during subsequent pandemic waves

EVT protocols during the COVID-19 pandemic

Anesthesia-specific guidelines for AIS management

Variations in EVT practices during the COVID-19 pandemic.

Impact of the pandemic on the stroke clinician.

Notes:

Includes bibliographical references and index.

Description based on publisher supplied metadata and other sources.

Part of the metadata in this record was created by AI, based on the text of the resource.

Description based on print version record.

ISBN:

0-443-18704-5

OCLC:

1440124482